Orthofix Medical Inc. (OFIX) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $16.27M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | -0.26× | Operating cash flow / net income. Period ending 2026-06-30. $16.27M ÷ $-61.72M ≈ -0.26× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 16.27M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 833.19M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -61.72M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $16.27M | (m) | (m) | $833.19M | (m) | $-61.72M | (m) | (m) | (m) | -0.26× |
| 2026-03-31 | (m) | (m) | $34.13M | (m) | (m) | $825.37M | (m) | $-60.00M | (m) | (m) | (m) | -0.57× |
| 2025-12-31 | (m) | (m) | $33.35M | (m) | (m) | $822.31M | (m) | $-92.19M | (m) | (m) | (m) | -0.36× |
| 2025-09-30 | (m) | (m) | $29.38M | (m) | (m) | $818.06M | (m) | $-119.12M | (m) | (m) | (m) | -0.25× |
| 2025-06-30 | (m) | (m) | $28.65M | (m) | (m) | $809.03M | (m) | $-123.71M | (m) | (m) | (m) | -0.23× |
| 2025-03-31 | (m) | (m) | $25.99M | (m) | (m) | $804.53M | (m) | $-143.07M | (m) | (m) | (m) | -0.18× |
| 2024-12-31 | (m) | (m) | $25.79M | (m) | (m) | $799.49M | (m) | $-126.00M | (m) | (m) | (m) | -0.20× |
| 2024-09-30 | $-44.40M | (m) | $-4.63M | $39.77M | (m) | $784.25M | (m) | $-119.03M | (m) | (m) | -5.66% | 0.04× |
| 2024-06-30 | $-72.15M | (m) | $-15.83M | $56.32M | (m) | $771.65M | (m) | $-120.49M | (m) | (m) | -9.35% | 0.13× |
| 2024-03-31 | $-89.66M | (m) | $-30.33M | $59.33M | (m) | $760.04M | (m) | $-126.48M | (m) | (m) | -11.80% | 0.24× |
| 2023-12-31 | $-106.01M | (m) | $-45.75M | $60.26M | (m) | $746.64M | (m) | $-151.40M | (m) | (m) | -14.20% | 0.30× |
| 2023-09-30 | $-87.61M | (m) | $-36.71M | $50.90M | (m) | $668.46M | (m) | $-136.28M | (m) | (m) | -13.11% | 0.27× |
| 2023-06-30 | $-72.61M | (m) | $-38.45M | $34.16M | (m) | $598.45M | (m) | $-118.14M | (m) | (m) | -12.13% | 0.33× |
| 2023-03-31 | $-65.36M | (m) | $-37.85M | $27.51M | (m) | $529.50M | (m) | $-76.23M | (m) | (m) | -12.34% | 0.50× |
| 2022-12-31 | $-32.90M | (m) | $-11.54M | $21.36M | (m) | $460.71M | (m) | $-19.75M | (m) | (m) | -7.14% | 0.58× |
| 2022-09-30 | $-24.49M | (m) | $-2.11M | $22.38M | (m) | $463.55M | (m) | $-45.50M | (m) | (m) | -5.28% | 0.05× |
| 2022-06-30 | $-14.19M | (m) | $5.59M | $19.78M | (m) | $461.98M | (m) | $-36.95M | (m) | (m) | -3.07% | -0.15× |
| 2022-03-31 | $-10.42M | (m) | $8.32M | $18.75M | (m) | $465.30M | (m) | $-37.02M | (m) | (m) | -2.24% | -0.22× |
| 2021-12-31 | $690.00K | (m) | $18.48M | $17.79M | (m) | $464.48M | (m) | $-38.38M | (m) | (m) | 0.15% | -0.48× |
| 2021-09-30 | $13.57M | (m) | $28.99M | $15.42M | (m) | $457.03M | (m) | $-14.95M | (m) | (m) | 2.97% | -1.94× |
| 2021-06-30 | $28.48M | (m) | $44.44M | $15.96M | (m) | $455.59M | (m) | $-8.12M | (m) | (m) | 6.25% | -5.47× |
| 2021-03-31 | $48.68M | (m) | $64.25M | $15.56M | (m) | $407.33M | (m) | $-28.96M | (m) | (m) | 11.95% | -2.22× |
| 2020-12-31 | $58.79M | (m) | $74.27M | $15.48M | (m) | $406.56M | (m) | $2.52M | (m) | (m) | 14.46% | 29.51× |
| 2020-09-30 | $47.04M | (m) | $63.92M | $16.89M | (m) | $410.44M | (m) | $23.58M | (m) | (m) | 11.46% | 2.71× |
| 2020-06-30 | $35.82M | (m) | $53.78M | $17.96M | (m) | $412.95M | (m) | $-21.57M | (m) | (m) | 8.67% | -2.49× |
| 2020-03-31 | $26.90M | (m) | $45.54M | $18.64M | (m) | $455.67M | (m) | $-3.69M | (m) | (m) | 5.90% | -12.33× |
| 2019-12-31 | $13.04M | (m) | $32.03M | $19.00M | (m) | $459.95M | (m) | $-28.46M | (m) | (m) | 2.83% | -1.13× |
| 2019-09-30 | $23.44M | (m) | $41.18M | $17.74M | (m) | $459.54M | (m) | $-31.28M | (m) | (m) | 5.10% | -1.32× |
| 2019-06-30 | $27.82M | (m) | $45.23M | $17.41M | (m) | $457.75M | (m) | $8.01M | (m) | (m) | 6.08% | 5.65× |
| 2019-03-31 | $37.03M | (m) | $52.44M | $15.40M | (m) | $453.44M | (m) | $9.48M | (m) | (m) | 8.17% | 5.53× |
| 2018-12-31 | $36.33M | (m) | $49.92M | $13.59M | (m) | $453.04M | (m) | $13.81M | (m) | (m) | 8.02% | 3.61× |
| 2018-09-30 | $60.23M | (m) | $73.05M | $12.81M | (m) | $448.86M | (m) | $6.51M | (m) | (m) | 13.42% | 11.22× |
| 2018-06-30 | $57.60M | (m) | $71.02M | $13.41M | (m) | $442.40M | (m) | $11.18M | (m) | (m) | 13.02% | 6.35× |
| 2018-03-31 | $46.91M | (m) | $60.68M | $13.78M | (m) | $439.79M | (m) | $14.10M | (m) | (m) | 10.67% | 4.30× |
| 2017-12-31 | $38.68M | (m) | $53.34M | $14.66M | (m) | $433.82M | (m) | $6.22M | (m) | (m) | 8.92% | 8.57× |
| 2017-09-30 | $14.87M | (m) | $29.80M | $14.94M | (m) | $425.46M | (m) | $1.42M | (m) | (m) | 3.49% | 21.00× |
| 2017-06-30 | $19.19M | (m) | $33.06M | $13.87M | (m) | $418.71M | (m) | $7.86M | (m) | (m) | 4.58% | 4.21× |
| 2017-03-31 | $29.46M | (m) | $43.53M | $14.07M | (m) | $413.85M | (m) | $-3.44M | (m) | (m) | 7.12% | -12.66× |
| 2016-12-31 | $28.27M | (m) | $44.71M | $16.43M | (m) | $409.79M | (m) | $3.06M | (m) | (m) | 6.90% | 14.63× |
| 2016-09-30 | $35.93M | (m) | $55.08M | $19.15M | (m) | $405.87M | (m) | $9.66M | (m) | (m) | 8.85% | 5.70× |
| 2016-06-30 | $32.23M | (m) | $55.54M | $23.30M | (m) | $408.53M | (m) | $-1.50M | (m) | (m) | 7.89% | -37.12× |
| 2016-03-31 | $16.90M | (m) | $45.10M | $28.21M | (m) | $405.41M | (m) | $9.46M | (m) | (m) | 4.17% | 4.77× |
| 2015-12-31 | $16.03M | (m) | $43.22M | $27.20M | (m) | $396.49M | (m) | $-2.81M | (m) | (m) | 4.04% | -15.39× |
| 2015-09-30 | $13.50M | (m) | $41.23M | $27.73M | (m) | $392.15M | (m) | $-11.98M | (m) | (m) | 3.44% | -3.44× |
| 2015-06-30 | $16.61M | (m) | $42.04M | $25.42M | (m) | $391.99M | (m) | $-10.15M | (m) | (m) | 4.24% | -4.14× |
| 2015-03-31 | $46.66M | (m) | $66.11M | $19.45M | (m) | $392.02M | (m) | $-14.41M | (m) | (m) | 11.90% | -4.59× |
| 2014-12-31 | $32.89M | (m) | $50.96M | $18.07M | (m) | $402.28M | (m) | $-8.54M | (m) | (m) | 8.18% | -5.97× |
| 2014-09-30 | $34.42M | (m) | $51.10M | $16.68M | (m) | $407.82M | (m) | $-13.15M | (m) | (m) | 8.44% | -3.89× |
| 2014-06-30 | $-3.07M | (m) | $15.03M | $18.10M | (m) | $398.69M | (m) | $-32.44M | (m) | (m) | -0.77% | -0.46× |
| 2014-03-31 | $19.20M | (m) | $41.64M | $22.45M | (m) | $398.50M | (m) | $-30.80M | (m) | (m) | 4.82% | -1.35× |
| 2013-12-31 | $42.09M | (m) | $66.88M | $24.79M | (m) | $400.53M | (m) | $-25.52M | (m) | (m) | 10.51% | -2.62× |
| 2013-09-30 | $-35.47M | (m) | $-6.26M | $29.21M | (m) | $411.76M | (m) | $3.52M | (m) | (m) | -8.61% | -1.78× |
| 2013-06-30 | $-41.44M | (m) | $-13.41M | $28.03M | (m) | $426.88M | (m) | $28.36M | (m) | (m) | -9.71% | -0.47× |
| 2013-03-31 | $-50.10M | (m) | $-22.45M | $27.65M | (m) | $446.53M | (m) | $41.40M | (m) | (m) | -11.22% | -0.54× |
| 2012-12-31 | $-16.79M | (m) | $11.21M | $27.99M | (m) | $462.32M | (m) | $51.30M | (m) | (m) | -3.63% | 0.22× |
| 2012-09-30 | $67.23M | (m) | $93.58M | $26.35M | (m) | $582.24M | (m) | (m) | (m) | (m) | 11.55% | (m) |
| 2012-06-30 | $72.34M | (m) | $99.13M | $26.80M | (m) | $584.79M | (m) | (m) | (m) | (m) | 12.37% | (m) |
| 2012-03-31 | $69.18M | (m) | $94.97M | $25.79M | (m) | $582.96M | (m) | (m) | (m) | (m) | 11.87% | (m) |
| 2011-12-31 | $39.82M | (m) | $64.78M | $24.96M | (m) | $578.99M | (m) | $-1.07M | (m) | (m) | 6.88% | -60.37× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | $564.71M | (m) | $-9.09M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $16.66M | (m) | $42.51M | $25.84M | (m) | $564.37M | (m) | $44.21M | (m) | (m) | 2.95% | 0.96× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $29.67M | (m) | $50.58M | $20.91M | (m) | $545.63M | (m) | (m) | (m) | (m) | 5.44% | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |